Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MTMR2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
JKAMP - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RNF144A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UBL3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GAPVD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TRPM6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
BACE1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ELMO2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCNT2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CEP350 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ALCAM - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FBXL7 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RBM22 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM165 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COMMD3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TPP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARID2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
USP54 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CSE1L - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC48A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on